OTCMKTS:BNKL - Bionik Laboratories Stock Price, News, & Analysis

0.00 (0.00 %)
(As of 06/14/2019 04:00 PM ET)
Today's Range
Now: $3.16
50-Day Range
MA: $4.09
52-Week Range
Now: $3.16
Volume1 shs
Average Volume106 shs
Market Capitalization$7.39 million
P/E RatioN/A
Dividend YieldN/A
Bionik Laboratories Corp., a robotics company, focuses on providing rehabilitation and mobility solutions to individuals with neurological and mobility challenges from hospital to home. The company specializes in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Systems, which include the InMotion ARM that allows clinicians to deliver sensor motor therapy to the shoulder and elbow to develop new neural pathways; InMotion ARM/HAND, an add-on module to be used with the InMotion ARM; and InMotion WRIST, a rehabilitation device that enables clinicians to deliver optimum intensive sensor motor wrist and forearm therapy to patients with neurological conditions. The company is also developing InMotion HOME, an upper extremity product that allows patients to extend their therapy for as long as needed while rehabilitating at home; and ARKE, a robotic lower body exoskeleton designed for wheelchair bound individuals suffering from spinal cord injuries, stroke, and other mobility disabilities. Bionik Laboratories Corp. was founded in 2010 and is headquartered in Toronto, Canada.

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Current SymbolOTCMKTS:BNKL



Sales & Book Value

Annual Sales$990,000.00
Book Value$12.23 per share


Net Income$-14,620,000.00
Net Margins-556.03%


Market Cap$7.39 million
Next Earnings Date6/26/2019 (Estimated)
OptionableNot Optionable

Receive BNKL News and Ratings via Email

Sign-up to receive the latest news and ratings for BNKL and its competitors with MarketBeat's FREE daily newsletter.

Bionik Laboratories (OTCMKTS:BNKL) Frequently Asked Questions

What is Bionik Laboratories' stock symbol?

Bionik Laboratories trades on the OTCMKTS under the ticker symbol "BNKL."

When is Bionik Laboratories' next earnings date?

Bionik Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, June 26th 2019. View Earnings Estimates for Bionik Laboratories.

Has Bionik Laboratories been receiving favorable news coverage?

Media stories about BNKL stock have trended somewhat positive this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Bionik Laboratories earned a news sentiment score of 1.5 on InfoTrie's scale. They also gave media stories about the company a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an impact on the company's share price in the next several days. View News Stories for Bionik Laboratories.

Who are some of Bionik Laboratories' key competitors?

What other stocks do shareholders of Bionik Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bionik Laboratories investors own include PerkinElmer (PKI), Mastercraft Boat (MCFT), Gray Television (GTN), Nuverra Environmental Solutions (NESCQ), Adobe (ADBE), Arch Capital Group (ACGL), Xtract Resources (XTR), DS Smith (SMDS), NEXT (NXT) and Jadestone Energy (JSE).

Who are Bionik Laboratories' key executives?

Bionik Laboratories' management team includes the folowing people:
  • Dr. Eric Michel Dusseux M.D., MSc, MBA, CEO & Director (Age 51)
  • Mr. Michal Prywata, Co-Founder, CTO & Director (Age 28)
  • Ms. Leslie N. Markow, Chief Financial Officer (Age 59)
  • Mr. William Harris, Marketing Director
  • Mr. Renaud Bertrand Maloberti, Chief Commercial Officer (Age 50)

How do I buy shares of Bionik Laboratories?

Shares of BNKL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bionik Laboratories' stock price today?

One share of BNKL stock can currently be purchased for approximately $3.16.

How big of a company is Bionik Laboratories?

Bionik Laboratories has a market capitalization of $7.39 million and generates $990,000.00 in revenue each year. Bionik Laboratories employs 27 workers across the globe.View Additional Information About Bionik Laboratories.

What is Bionik Laboratories' official website?

The official website for Bionik Laboratories is http://www.bioniklabs.com/.

How can I contact Bionik Laboratories?

Bionik Laboratories' mailing address is 483 Bay Street N105, Toronto A6, M5G2C9. The company can be reached via phone at 1-416-640-7887 or via email at https://ir.bioniklabs.com.

MarketBeat Community Rating for Bionik Laboratories (OTCMKTS BNKL)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  60 (Vote Outperform)
Underperform Votes:  61 (Vote Underperform)
Total Votes:  121
MarketBeat's community ratings are surveys of what our community members think about Bionik Laboratories and other stocks. Vote "Outperform" if you believe BNKL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BNKL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/15/2019 by MarketBeat.com Staff

Featured Article: Quick Ratio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel